Found: 125
Select item for more details and to access through your institution.
Role of telemedicine in the management of obesity: State‐of‐the‐art review.
- Published in:
- Obesity Reviews, 2024, v. 25, n. 6, p. 1, doi. 10.1111/obr.13734
- By:
- Publication type:
- Article
Endpoint adjudication in cardiovascular clinical trials.
- Published in:
- European Heart Journal, 2023, v. 44, n. 46, p. 4835, doi. 10.1093/eurheartj/ehad718
- By:
- Publication type:
- Article
Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials.
- Published in:
- European Heart Journal, 2023, v. 44, n. 21, p. 1890, doi. 10.1093/eurheartj/ehad171
- By:
- Publication type:
- Article
Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e220035, doi. 10.1001/jamanetworkopen.2022.0035
- By:
- Publication type:
- Article
Watchman implantation in a patient with left atrial appendage thrombus.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Web Exclusive. Annals for Hospitalists Inpatient Notes - Clinical Pearls-Stopping, Starting, and Optimizing Guideline-Directed Medical Therapy in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Mechanisms of current therapeutic strategies for heart failure: more questions than answers?
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 18, p. 3467, doi. 10.1093/cvr/cvac187
- By:
- Publication type:
- Article
Bio‐adrenomedullin: A weak biomarker for a STRONG patient.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1493, doi. 10.1002/ejhf.3351
- By:
- Publication type:
- Article
On‐treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post‐hoc analysis of TRANSFORM‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 7, p. 1518, doi. 10.1002/ejhf.3293
- By:
- Publication type:
- Article
Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID‐19 infection: The PARACOR‐19 randomized clinical trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1393, doi. 10.1002/ejhf.3199
- By:
- Publication type:
- Article
Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure – insights from TRANSFORM‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 5, p. 1242, doi. 10.1002/ejhf.3207
- By:
- Publication type:
- Article
Use of natriuretic peptides and echocardiography for diagnosing heart failure.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 3, p. 551, doi. 10.1002/ejhf.3165
- By:
- Publication type:
- Article
Guideline‐directed medical therapy for heart failure: The key ingredient for successful in‐hospital and post‐discharge care.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 355, doi. 10.1002/ejhf.3152
- By:
- Publication type:
- Article
Why do clinicians not prescribe quadruple medical therapy for heart failure with reduced ejection fraction?
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 338, doi. 10.1002/ejhf.3133
- By:
- Publication type:
- Article
Sex differences in long‐term outcomes following acute heart failure hospitalization: Findings from the Get With The Guidelines‐Heart Failure registry.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1544, doi. 10.1002/ejhf.3003
- By:
- Publication type:
- Article
Implementation of sodium–glucose cotransporter 2 inhibitors for heart failure with reduced ejection fraction: Where we are versus where we need to be.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1659, doi. 10.1002/ejhf.2999
- By:
- Publication type:
- Article
Artificial intelligence and heart failure: A state‐of‐the‐art review.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1507, doi. 10.1002/ejhf.2994
- By:
- Publication type:
- Article
Potential global impact of sodium–glucose cotransporter‐2 inhibitors in heart failure.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 999, doi. 10.1002/ejhf.2864
- By:
- Publication type:
- Article
Intersection of atrial fibrillation and heart failure with mildly reduced and preserved ejection fraction in >400 000 participants in the Get With The Guidelines‐Heart Failure Registry.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 1, p. 63, doi. 10.1002/ejhf.2729
- By:
- Publication type:
- Article
Outpatient versus inpatient intravenous diuretic therapy for heart failure in the United States.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 11, p. 2199, doi. 10.1002/ejhf.2727
- By:
- Publication type:
- Article
Sodium–glucose cotransporter 2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: time to deliver implementation.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1902, doi. 10.1002/ejhf.2688
- By:
- Publication type:
- Article
Classifying heart failure based on ejection fraction: imperfect but enduring.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 7, p. 1154, doi. 10.1002/ejhf.2470
- By:
- Publication type:
- Article
Heart failure quality of care and in‐hospital outcomes during the COVID‐19 pandemic: findings from the Get With The Guidelines‐Heart Failure registry.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 6, p. 1117, doi. 10.1002/ejhf.2484
- By:
- Publication type:
- Article
Prioritizing prevention of de novo and worsening chronic heart failure.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 653, doi. 10.1002/ejhf.2464
- By:
- Publication type:
- Article
Sodium–glucose co‐transporter 2 inhibitors as an early, first‐line therapy in patients with heart failure and reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 431, doi. 10.1002/ejhf.2397
- By:
- Publication type:
- Article
In‐hospital initiation of quadruple medical therapy for heart failure: making the post‐discharge vulnerable phase far less vulnerable.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 1, p. 227, doi. 10.1002/ejhf.2382
- By:
- Publication type:
- Article
Effect of patient‐centered transitional care services on patient‐reported outcomes in heart failure: sex‐specific analysis of the PACT‐HF randomized controlled trial.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 9, p. 1488, doi. 10.1002/ejhf.2312
- By:
- Publication type:
- Article
Simultaneous or rapid sequence initiation of medical therapies for heart failure: seeking to avoid the case of 'too little, too late'.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 9, p. 1514, doi. 10.1002/ejhf.2311
- By:
- Publication type:
- Article
Another reason to embrace quadruple medical therapy for heart failure: medications enabling tolerance of each other.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 9, p. 1525, doi. 10.1002/ejhf.2301
- By:
- Publication type:
- Article
Dietary interventions and nutritional supplements for heart failure: a systematic appraisal and evidence map.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 9, p. 1468, doi. 10.1002/ejhf.2278
- By:
- Publication type:
- Article
Clinical inertia and medical therapy for heart failure: the unintended harms of 'first, do no harm'.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 8, p. 1343, doi. 10.1002/ejhf.2283
- By:
- Publication type:
- Article
Sodium–glucose co‐transporter 2 inhibitors for heart failure: clinical trial efficacy and clinical practice effectiveness.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 6, p. 1023, doi. 10.1002/ejhf.2170
- By:
- Publication type:
- Article
The real world of de novo heart failure: the next frontier for heart failure clinical trials?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Trends in prevalence of comorbidities in heart failure clinical trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Patient-reported outcomes for heart failure with preserved ejection fraction: conducting quality studies on quality of life.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Diagnosing heart failure with preserved ejection fraction in 2019: the search for a gold standard.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial.
- Published in:
- 2020
- By:
- Publication type:
- clinical trial
Haemoconcentration during treatment of acute heart failure with cardiorenal syndrome: from the CARRESS-HF trial.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Erratum to 'The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions' [Eur J Heart Fail 2018;20:963-972].
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Medication dosing for heart failure with reduced ejection fraction - opportunities and challenges.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outpatient versus inpatient worsening heart failure: distinguishing biology and risk from location of care.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trial.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Nomenclature in heart failure: a call for objective, reproducible, and biologically-driven terminology.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Globalization of heart failure clinical trials: a systematic review of 305 trials conducted over 16 years.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Potential advantages of torsemide in patients with heart failure: more than just a 'water pill'?
- Published in:
- 2018
- By:
- Publication type:
- Editorial